Europe Mass Spectrometry Market worth USD 2.83 billion by 2031
The report "Europe Mass Spectrometry Market by Component (Detector, Mass Analyzer, Ion Source, Vacuum System), Product (Triple Quad, Q-ToF, FTMS, Quad, ToF), Application (Omics, Environment, Pharma, Biopharma) - Forecast to 2031" is estimated to reach USD 2.83 billion by 2031, up from USD 1.83 billion in 2025, at a CAGR of 7.6% during the forecast period.
Browse 200 market data Tables and 80 Figures spread through 250 Pages and in-depth TOC on "Europe Mass Spectrometry Market by Component (Detector, Mass Analyzer, Ion Source, Vacuum System), Product (Triple Quad, Q-ToF, FTMS, Quad, ToF), Application (Omics, Environment, Pharma, Biopharma) - Forecast to 2031"
View detailed Table of Content here - https://www.marketsandmarkets.com/Market-Reports/europe-mass-spectrometry-market-233897614.html
European market growth is supported by the continuous penetration of MS into mainstream workflows across pharma-biopharma manufacturing, translational research, applied testing, and regulated laboratories. Also, market demand is being propelled by stringent regulatory expectations for data integrity, trace-level impurity profiling, and method standardization, which are pushing F&B and pharma-biopharma laboratories to replace legacy techniques with high-resolution and tandem MS platforms. At the same time, innovations in ionization sources, high-speed acquisition, and microflow LC are improving sensitivity, throughput, and robustness, making MS suitable for both discovery and high-volume routine analysis. Growing use of automation, cloud-based data processing, and AI-driven spectral interpretation is further lowering barriers to adoption by simplifying complex workflows. Additionally, progress in data processing, automated analysis, machine learning, and software tools is further supporting adoption by enabling efficient handling of complex datasets.
The mass analyzers segment accounted for the largest share of the Europe mass spectrometry market in 2025.
By component, the market for Europe mass spectrometers is categorized into mass analyzers, detectors, ion sources, sample introduction systems, ion optics & interface systems, and other components. Mass analyzers dominate as a component driven by the fact that it is the core performance-determining module—the component that sets the ceiling for resolution, mass accuracy, scan speed, dynamic range, and selectivity. As clinical and applied labs move toward more complex matrices and multiplexed workflows, they increasingly upgrade to higher-performance analyzer architectures and hybrids (e.g., quadrupole + high-resolution stages) to improve confidence in identification/quantitation and reduce ambiguity. Vendors have also been pushing continual analyzer innovation because environmental testing demands faster, more sensitive, higher-performance instruments—and those gains are fundamentally delivered through analyzer design improvements.
Instruments, as a product segment, accounted for a significant share of the mass spectrometry market in 2025.
Instruments remain the dominant revenue contributor in the European MS market, with hybrid systems such as triple quadrupole-LC-MS/MS, Q-TOF, and FT-MS at the forefront. These platforms are increasingly favored for their ability to deliver sub-ppm mass accuracy, wide dynamic range, and multiplexed quantification in complex matrices – capabilities critical for peptide mapping, impurity profiling, metabolite identification, and targeted bioanalysis. High-performance LC-MS and GC-MS configurations are also seeing strong uptake in food safety, environmental testing, and industrial applications, where laboratories demand quick TAT, rugged performance, and automated compliance reporting. As European pharma-biopharma manufacturers intensify their focus on biologics, advanced therapies, and data-driven quality control, MS instrument sales are expected to outpace software and services, while simultaneously catalyzing recurring revenue streams from upgrades, application-specific software, and long-term service contracts.
The omics research as an application segment acquired a major share of Europe mass spectrometry market in 2025.
Omics continues to command the largest share of the Europe mass spectrometry market, as laboratories rely on MS for molecular profiling across proteomics, metabolomics, lipidomics, and related disciplines. In proteomics, advanced MS platforms enable precise quantification of protein expression, post-translational modifications, and protein–protein interactions, turning complex samples into actionable biological insights. In metabolomics, MS allows ultra-sensitive detection of small-molecule metabolites and pathway intermediates, supporting disease mechanism studies and biomarker discovery. Coupling MS with separation techniques such as gas chromatography, liquid chromatography, and UHPLC empowers researchers to resolve and analyze hundreds to thousands of components within a single run. The rapid evolution of high-resolution, accurate-mass systems, together with richer spectral libraries and cloud-based databases, is lifting confidence in identification and quantitation. In lipidomics, MS delivers detailed structural and quantitative information on lipid species tied to cell signaling, inflammation, and drug response.
European Mass Spectrometry Market – Sustained Growth and Strong Regional Presence
The European mass spectrometry market is poised for strong and sustained growth as the region doubles down on innovation in pharmaceutical and biopharmaceutical R&D, advanced manufacturing, and regulated testing. Rising expectations from regulators on impurity profiling, data integrity, and method robustness are pushing pharma and biopharma companies to standardize on LC-MS and GC-MS platforms for both development and QC. At the same time, expanding food safety regulations, environmental monitoring mandates, and the growth of clinical toxicology and specialty diagnostics are broadening the installed base beyond traditional research centers. Countries such as Germany, the UK, France, the Netherlands, and the Nordics are at the forefront of adoption, with universities, research institutes, and contract labs continuously refreshing their MS fleets to support cutting-edge omics and precision medicine programs. Europe’s policy focuses on sustainability and green chemistry, combined with the vibrant start-up ecosystem in life sciences and analytical technologies, is further catalyzing investment in high-throughput, energy-efficient mass spectrometry solutions.
Major Market Players in the Europe Mass Spectrometry Market
The competitive landscape in Europe is characterized by a mix of global instrument manufacturers, specialized software and consumables providers, and regional service organizations. Leading participants span high-resolution MS platforms, triple quadrupole systems, MALDI and hybrid configurations, complemented by vendors offering chromatography front ends, informatics, data-analysis tools, and application-specific reagents. Strategic partnerships with CROs, clinical laboratories, and academic centers, together with localized service and application-support teams across major European countries, remain critical levers for capturing share and sustaining long-term customer relationships.
The key players profiled in the Europe mass spectrometry market are Agilent Technologies, Inc. (US), Thermo Fisher Scientific, Inc. (US), Analytik Jena GmbH & Co. KG (Germany), Danaher Corporation (US), Waters Corporation (US), Hiden Analytical (UK), Scion Instruments (Scotland), Kore Technology (UK), Spacetek Technology AG (Switzerland), Elementar Analysensysteme GMBH (Germany), Microsaic (UK), and Pfeiffer Vacuum+ Fab Solutions (Germany), among others.
About MarketsandMarkets™
MarketsandMarkets™ has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report.
MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe.
Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem.
The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.
Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts.
To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter , LinkedIn and Facebook .
Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com
Visit Our Website: https://www.marketsandmarkets.com
- Triangulate with your Own Data
- Get Data as per your Format and Definition
- Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
- Any level of Personalization
- What are the Known and Unknown Adjacencies Impacting the Europe Mass Spectrometry Market
- What will your New Revenue Sources be?
- Who will be your Top Customer; what will make them switch?
- Defend your Market Share or Win Competitors
- Get a Scorecard for Target Partners
